Dear Colleagues,

Cancer nanomedicine has introduced new possibilities in cancer diagnostics and therapies, aiming to overcome the disadvantages of conventional diagnostic and therapy approaches. Nevertheless, despite the significant interest in and attractive possibilities of nanotechnologies, there are still challenges in its clinical translation. We expect this Special Issue to cover strategies to realise the unlimited promise of nanomedicine for the detection, diagnosis and efficient treatment of cancer.

Please note that the Special Issue is focused on molecular research; therefore, pure clinical research will not be accepted, but clinical submissions on biomolecular experiments are welcomed.

Dr. Maria Gazouli
Dr. Kalevi Kairemo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cancer
• nanomedicine
• nanoparticles
• hyperthermia
• nanodrug delivery
• nanotoxicity
• nanodiagnostics